More Business Wire
View Older Stories View Newer Stories-
Azul State of Java Survey & Report 2023: 82% of Businesses Using Java Today Are Concerned With Oracle’s Fourth Major Change to Its Licensing/Pricing Policies, and 72% Are Exploring Java Alternat
-
Bragg Gaming Expands iGaming Content Reach in Italy with Lottomatica
-
AirWorks Announces Strategic Growth Investment Led by PSG
-
Scorpion Therapeutics Appoints Precision Medicine Leader Jeff Albers as Strategic Advisor
-
NetApp Extends Its Storage Leadership and Innovation at INSIGHT 2023 with the Only Unified Data Storage Across On-premises and Public Cloud
-
Adtran launches Wi-Fi 6, 6E and 7 mesh routers for optimized in-home connectivity
-
Northern Trust Hosts Second Charity Trading Day to Benefit Four Global Charities
-
Cantaloupe, Inc. to Report First Quarter Fiscal Year 2024 Results on November 9, 2023
-
City Holding Company Announces Quarterly Results
-
HCA Healthcare Reports Third Quarter 2023 Results
-
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
-
The Real Brokerage Announces New Brand Positioning; Game-Changing Marketing Tools For Its Agents
-
Industrial Safety Trainers Partners with Mentor Safety, Expanding Geographic Reach
-
HOME by Funnel Inc. Makes First Donation to Partner Organization: Entryway
-
Dealmaker Optimism Rebounds in Q3 as Private Equity Increases Projects in Portfolio Companies
-
Savvy Advisors Recruits Michael Most as Principal Wealth Manager Amid Period of Strong Growth
-
Fiserv Reports Third Quarter 2023 Results
-
Marinus Pharmaceuticals to Provide Business Update and Report Third Quarter 2023 Financial Results on November 7, 2023
-
Asbury Automotive Group Reports Third Quarter 2023 Financial Results
-
Mueller Industries, Inc. Reports Third Quarter 2023 Earnings
-
Ares Capital Corporation Announces September 30, 2023 Financial Results and Declares Fourth Quarter 2023 Dividend of $0.48 Per Share
-
ADM Reports Third Quarter Earnings per Share of $1.52, $1.63 on an Adjusted Basis
-
nVent Named to Newsweek’s America’s Greenest Companies 2024
-
Partnership on AI Releases Guidance for Safe Foundation Model Deployment, Takes the Lead to Drive Positive Outcomes and Help Inform AI Governance Ahead of AI Safety Summit in UK
-
Wedgewood Named to Inc.’s Second Annual Power Partner Awards
-
ReposiTrak Traceability Network Adds East Coast Seafood Suppliers
-
Old Dominion Freight Line Receives Prestigious Mastio Quality Award for the 14th Consecutive Year
-
CI Financial Reports Total Assets of $421.0 Billion for September 2023
-
Castle Biosciences to Present New Data on its TissueCypher® Barrett’s Esophagus Test at the 2023 American College of Gastroenterology Annual Scientific Meeting
-
Laser Photonics Commences Pre-Orders for Its AI-Capable CleanTech Robotic Cell Enclosure
-
Blackhawk Network (BHN) and Extole Join Forces to Power Next Generation Referral Marketing Capabilities and Rewards
-
H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker
-
ICPO Foundation Announcing Official Launch of Its ICPO Academy for Theranostics During Its 3rd Forum for Theranostics in Precision Oncology on October 12th and 13th in Garching Munich
-
Neurocentrx Reports Positive Top-line Results from Phase 1 Clinical Study of its Lead Oral Ketamine Capsule Programme
-
FEDML Nexus AI: The Next-Gen Cloud Services for LLMs and Generative AI
-
908 Devices to Report Third Quarter Financial Results on November 7, 2023
-
US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FLUMIST® QUADRIVALENT (Influenza Vaccine Live, Intranasal)
-
MCO Joins Prestigious Chartis Research RiskTech 100
-
Montrose Environmental Group Announces Timing of Third Quarter 2023 Results
-
Upstream Bio Announces Positive Phase 1b Interim Data in Asthma and Company Progress Toward Phase 2
-
Rampart Bioscience Announces $85M Series A Financing to Develop Novel DNA-Based Medicines with Veteran Team
-
ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
-
KaliVir Immunotherapeutics Announces FDA Clearance of Investigational New Drug (IND) for Systemic Oncolytic Virus ASP1012 for Phase I Clinical Trials for Locally Advanced or Metastatic Solid Tumors
-
Keyfactor Announces Significant Minority Investment From Sixth Street Growth, Valuing the Company at Approximately $1.3B
-
Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
-
Many Tech Professionals Will Look for New Jobs, New Employers in 2024
-
MarketReader Launches Equity and Macro Insight API Streams for Enterprise
-
Karen Clark & Company Launches RiskInsight® Version 4.13
-
Bristol Myers Squibb Announces U.S. FDA Breakthrough Therapy Designation for Investigational LPA1 Antagonist for Progressive Pulmonary Fibrosis
-
Pentair Reports Strong Third Quarter 2023 Results
